The rationale, design, and baseline characteristics of PREVENT-DM: A community-based comparative effectiveness trial of lifestyle intervention and metformin among Latinas with prediabetes

Contemporary Clinical Trials

Volumn 45, Issue , 2015, Pages 320-327

  Perez, Alberly ^a,b   Alos, Victor A ^a,b   Scanlan, Adam ^c   Maia, Catarina M ^a,b   Davey, Adam ^a   Whitaker, Robert C ^a   Foster, Gary D ^d   Ackermann, Ronald T ^e   O'Brien, Matthew J ^e  

^a TEMPLE UNIVERSITY   (United States)

^b Puentes de Salud Health Center   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Weight Watchers International   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Diabetes prevention; Hispanic Americans; Lifestylei intervention; Metformin; Obesity

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; TRIACYLGLYCEROL; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; LIPID;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIABETES MELLITUS; EDUCATIONAL STATUS; ETHNIC GROUP; FEMALE; FIRST DEGREE RELATIVE; GLUCOSE BLOOD LEVEL; HISPANIC; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; PREGNANCY DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; SEX; STUDY DESIGN; TREATMENT OUTCOME; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; BLOOD; DIABETES MELLITUS, TYPE 2; DIET; ETHNOLOGY; EXERCISE; HEALTH AUXILIARY; HEALTH BEHAVIOR; HEALTH PROMOTION; LIFESTYLE; METHODOLOGY; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PREDIABETIC STATE; PROCEDURES; RISK FACTOR; SOCIOECONOMICS; UNITED STATES; WEIGHT LOSS PROGRAM;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; COMMUNITY HEALTH WORKERS; COMPARATIVE EFFECTIVENESS RESEARCH; DIABETES MELLITUS, TYPE 2; DIET; EXERCISE; FEMALE; HEALTH BEHAVIOR; HEALTH PROMOTION; HEMOGLOBIN A, GLYCOSYLATED; HISPANIC AMERICANS; HUMANS; HYPOGLYCEMIC AGENTS; LIFE STYLE; LIPIDS; METFORMIN; MIDDLE AGED; PREDIABETIC STATE; RESEARCH DESIGN; RISK FACTORS; SOCIOECONOMIC FACTORS; UNITED STATES; WAIST CIRCUMFERENCE; WEIGHT REDUCTION PROGRAMS;

EID: 84946594155     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2015.10.011     Document Type: Article

References (72)

1. Centers for Disease Control and Prevention National diabetes statistics report: estimates and its burden in the United States. The Department of Health and Human Services 2014, (Vol 2014. Atlanta, GA).
2. Zhang X., Gregg E.W., Williamson D.F., et al. A1C level and future risk of diabetes: a systematic review. Diabetes Care 2010, 33(7):1665-1673. 10.2337/dc09-1939.
3. Cowie C.C., Rust K.F., Ford E.S., et al. Full accounting of diabetes and pre-diabetes in the US population in 1988-1994 and 2005-2006. Diabetes Care 2009, 32(2):287-294. 10.2337/dc08-1296.
4. Narayan K.M.V., Boyle J.P., Thompson T.J., Sorensen S.W., Williamson D.F. Lifetime risk for diabetes mellitus in the United States. JAMA 2003, 290(14):1884-1890. 10.1001/jama.290.14.1884.
5. Krogstad J.M., Lopez M.H. Hispanic Nativity Shift: US Births Drive Population Growth as Immigration Stalls 2014, Pew Research Center's Hispanic Trends Project, Washington, DC.
6. Knowler W., Barrett-Connor E., Fowler S., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 2002, 346(6). 10.1056/NEJMoa012512.
7. Pan X.R., Li G., Hu Y.H., et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and diabetes study. Diabetes Care 1997, 20(4):537-544. 10.2337/diacare.20.4.537.
8. Tuomilehto J., Lindström J., Eriksson J.G., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 2001, 344(18):1343-1350. 10.1056/NEJM200105033441801.
9. Ali M.K., Echouffo-Tcheugui J., Williamson D.F. How effective were lifestyle interventions in real-world settings that were modeled on the diabetes prevention program?. Health Aff. 2012, 31(1):67-75. 10.1377/hlthaff.2011.1009.
10. Ramachandran A., Snehalatha C., Mary S., et al. The Indian diabetes prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006, 49(2):289-297. 10.1007/s00125-005-0097-z.
11. O'Brien M.J., Whitaker R.C., Yu D., Ackermann R.T. The comparative efficacy of lifestyle intervention and metformin by educational attainment in the diabetes prevention program. Prev. Med. 2015, 10.1016/j.ypmed.2015.05.017.
12. O'Brien M.J., Shuman S.J., Barrios D.M., Alos V.A., Whitaker R.C. A qualitative study of acculturation and diabetes risk among urban immigrant Latinas: implications for diabetes prevention efforts. Diabetes Educ. 2014, 40(5):616-625. 10.1177/0145721714535992.
13. Miranda A.O., Bilot J.M., Peluso P.R., Berman K., Van Meek L.G. Latino families: the relevance of the connection among acculturation, family dynamics, and health for family counseling research and practice. Fam. J. 2006, 14(3):268-273. 10.1177/1066480706287805.
14. Martinez S.M., Arredondo E.M., Perez G., Baquero B. Individual, social, and environmental barriers to and facilitators of physical activity among Latinas living in San Diego County: focus group results. J. Fam. Health Care 2009, 32(1):22-33. 10.1097/01.FCH.0000342814.42025.6d.
15. American Diabetes Association 2. Classification and diagnosis of diabetes. Diabetes Care 2015, 38(Supplement 1):S8-S16. 10.2337/dc15-S005.
16. Vella C.A., Burgos X., Ellis C.J., et al. Associations of insulin resistance with cardiovascular risk factors and inflammatory cytokines in normal-weight Hispanic women. Diabetes Care 2013, 36(5):1377-1383. 10.2337/dc12-1550.
17. Holman R.R., Paul S.K., Bethel M.A., Matthews D.R., Neil H.A.W. 10-year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med. 2008, 359(15):1577-1589. 10.1056/NEJMoa0806470.
18. UK Prospective Diabetes Study Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998, 352(9131):854-865. 10.1016/S0140-6736(98)07037-8.
19. Diabetes Prevention Program Research Group Effects of withdrawal from metformin on the development of diabetes in the diabetes prevention program. Diabetes Care 2003, 26(4):977-980. 10.2337/diacare.26.4.977.
20. Salpeter S.R., Buckley N.S., Kahn J.A., Salpeter E.E. Meta-analysis: metformin treatment in persons at risk for diabetes mellitus. Am. J. Med. 2008, 121(2):149-157. (e142). 10.1016/j.amjmed.2007.09.016.
21. Lachin J.M., Christophi C.A., Edelstein S.L., et al. Factors associated with diabetes onset during metformin versus placebo therapy in the diabetes prevention program. Diabetes 2007, 56(4):1153-1159. 10.2337/db06-0918.
22. Diabetes Prevention Program Research Group Long-term safety, tolerability, and weight loss associated with metformin in the diabetes prevention program outcomes study. Diabetes Care 2012, 35:731-737. 10.2337/dc11-1299.
23. Hoeger K.M., Kochman L., Wixom N., et al. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study. Fertil. Steril. 2004, 82(2):421-429. 10.1016/j.fertnstert.2004.02.104.
24. Ng E.H.Y., Wat N.M.S., Ho P.C. Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial. Hum. Reprod. 2001, 16(8):1625-1631. 10.1093/humrep/16.8.1625.
25. Rhodes S.D., Foley K.L., Zometa C.S., Bloom F.R. Lay health advisor interventions among Hispanics/Latinos: a qualitative systematic review. Am. J. Prev. Med. 2007, 33(5):418-427. 10.1016/j.amepre.2007.07.023.
26. O'Brien M.J., Squires A.P., Bixby R.A., Larson S.C. Role development of community health workers: an examination of selection and training processes in the intervention literature. Am. J. Prev. Med. 2009, 37(6 Suppl. 1):S262-S269. 10.1016/j.amepre.2009.08.011.
27. Rosenthal E.L., Brownstein J.N., Rush C.H., et al. Community health workers: part of the solution. Health Aff. 2010, 29(7):1338-1342. 10.1377/hlthaff.2010.0081.
28. Perez L.M., Martinez J. Community health workers: social justice and policy advocates for community health and well-being. Am. J. Public Health 2008, 98(1). 10.2105/AJPH.2006.100842.
29. Ackermann R.T., Finch E.A., Brizendine E., Zhou H., Marrero D.G. Translating the diabetes prevention program into the community. The DEPLOY pilot study. Am. J. Prev. Med. 2008, 35(4):357-363. 10.1016/j.amepre.2008.06.035.
30. Parikh P., Simon E.P., Fei K., et al. Results of a pilot diabetes prevention intervention in East Harlem, New York City: project HEED. Am. J. Public Health 2010, 100(Suppl. 1):S232-S239. 10.2105/AJPH.2009.170910.
31. Mau M.K., Keawe'aimoku Kaholokula J., West M.R., et al. Translating diabetes prevention into native Hawaiian and Pacific islander communities: the PILI 'Ohana pilot project. Prog. Community Health Partnersh. 2010, 4(1):7-16. 10.1353/cpr.0.0111.
32. Faridi Z., Shuval K., Njike V.Y., et al. Partners reducing effects of diabetes (PREDICT): a diabetes prevention physical activity and dietary intervention through African-American churches. Health Educ. Res. 2010, 25(2):306-315. 10.1093/her/cyp005.
33. Katula J.A., Vitolins M.Z., Rosenberger E.L., et al. One-year results of a community-based translation of the diabetes prevention program. Diabetes Care 2011, 34(7):1451-1457. 10.2337/dc10-2115.
34. O'Brien M.J., Perez A., Alos V.A., et al. The feasibility, acceptability, and preliminary effectiveness of a promotora-led diabetes prevention program (PL-DPP) in Latinas: a pilot study. Diabetes Educ. 2015, 10.1177/0145721715586576.
35. Heshka S., Anderson J.W., Atkinson R.L., et al. Weight loss with self-help compared with a structured commercial program: a randomized trial. JAMA 2003, 289(14):1792-1798. 10.1001/jama.289.14.1792.
36. Katula J.A., Vitolins M.Z., Rosenberger E.L., et al. Healthy living partnerships to prevent diabetes (HELP PD): design and methods. Contemp. Clin. Trials 2010, 31(1):71-81. 10.1016/j.cct.2009.09.002.
37. Diabetes Prevention Program Research Group The diabetes prevention program (DPP) description of lifestyle intervention. Diabetes Care 2002, 25(12):2165-2171. 10.2337/diacare.25.12.2165.
38. Kramer M.K., Kriska A.M., Venditti E.M., et al. Translating the diabetes prevention program: a comprehensive model for prevention training and program delivery. Am. J. Prev. Med. 2009, 37(6):505-511. 10.1016/j.amepre.2009.07.020.
39. University of Pittsburgh. Diabetes Prevention Support Center. /. (Accessed February 6, 2015). http://www.diabetesprevention.pitt.edu.
40. O'Brien M.J., Davey A., Alos V.A., Whitaker R.C. Diabetes-related behaviors in Latinas and non-Latinas in California. Diabetes Care 2013, 36(2):355-361. 10.2337/dc12-0548.
41. Center for Disease Control and Prevention National Diabetes Prevention Program Lifestyle Coach and Master Training (Accessed July 29, 2015). http://www.cdc.gov/diabetes/prevention/training.htm.
42. National Diabetes Education Program Publications (Accessed July 15, 2015). http://ndep.nih.gov/publications/index.aspx.
43. Geiss L.S., James C., Gregg E.W., et al. Diabetes risk reduction behaviors among U.S. adults with prediabetes. Am. J. Prev. Med. 2010, 38(4):403-409. 10.1016/j.amepre.2009.12.029.
44. American Diabetes Association Diabetes Risk Test 2011, American Diabetes Association, Alexandria, VA.
45. Hamman R.F., Wing R.R., Edelstein S.L., et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care 2006, 29(9):2102-2107. 10.2337/dc06-0560.
46. Davis L.L., Broome M.E., Cox R.P. Maximizing retention in community-based clinical trials. J. Nurs. Scholarsh. 2002, 34(1):47-53. 10.1111/j.1547-5069.2002.00047.x.
47. Look AHEAD Research Group The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity 2006, 14(5):737. 10.1038/oby.2006.84.
48. Little R.R. Glycated hemoglobin standardization-National Glycohemoglobin Standardization Program (NGSP) perspective. Clin. Chem. Lab. Med. 2003, 41(9):1191-1198. 10.1515/CCLM.2003.183.
49. Parker R.M., Baker D.W., Williams M.V., Nurss J.R. The test of functional health literacy in adults. J. Gen. Intern. Med. 1995, 10(10):537-541. 10.1007/BF02640361.
50. Ware J.E., Kosinski M., Keller S.D. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med. Care 1996, 34(3):220-233.
51. Marin G., Sabogal F., Marin B.V., Otero-Sabogal R., Perez-Stable E.J. Development of a short acculturation scale for Hispanics. Hisp. J. Behav. Sci. 1987, 9(2):183-205. 10.1177/07399863870092005.
52. Zimet G.D., Dahlem N.W., Zimet S.G., Farley G.K. The multidimensional scale of perceived social support. J. Pers. Assess. 1988, 52(1):30-41. 10.1207/s15327752jpa5201_2.
53. Cohen S., Kamarck T., Mermelstein R. A global measure of perceived stress. J. Health Soc. Behav. 1983, 385-396. 10.13072/midss.461.
54. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961, 4:561. 10.1001/archpsyc.1961.01710120031004.
55. Spitzer R., Kroenke K., Williams J., Lowe B. A brief measure for assessing generalized anxiety disorder - the GAD-7. Arch. Intern. Med. 2006, 166(10):1092-1097. 10.1001/archinte.166.10.1092.
56. Collins L.M. Sayer AG 2001, American Psychological Association, New methods for the analysis of change.
57. Schafer J.L. Analysis of Incomplete Multivariate Data 1997, CRC press.
58. Molenberghs G., Kenward M. Missing Data in Clinical Studies 2007, vol. 61. John Wiley & Sons.
59. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/national heart, lung, and blood institute scientific statement. Circulation 2005, 112(17):2735-2752. 10.1161/CIRCULATIONAHA.105.169404.
60. Ackermann R.T., Finch E.A., Schmidt K.K., et al. Rationale, design, and baseline characteristics of a community-based comparative effectiveness trial to prevent type 2 diabetes in economically disadvantaged adults: the RAPID study. Contemp. Clin. Trials 2014, 37(1):1-9. 10.1016/j.cct.2013.10.003.
61. Blackwell C.S., Foster K.A., Isom S., et al. Healthy living partnerships to prevent diabetes: recruitment and baseline characteristics. Contemp. Clin. Trials 2011, 32(1):40-49. 10.1016/j.cct.2010.10.006.
62. Lovato L.C., Hill K., Hertert S., Hunninghake D.B., Probstfield J.L. Recruitment for controlled clinical trials: literature summary and annotated bibliography. Control. Clin. Trials 1997, 18(4):328-352. 10.1016/S0197-2456(96)00236-X.
63. Sung N.S., Crowley W.F., Genel M., et al. Central challenges facing the national clinical research enterprise. JAMA 2003, 289(10):1278-1287. 10.1001/jama.289.10.1278.
64. Brown H.S., Wilson K.J., Pagan J.A., et al. Cost-effectiveness analysis of a community health worker intervention for low-income Hispanic adults with diabetes. Prev. Chronic Dis. 2012, 9. 10.5888/pcd9.120074.
65. Katzen A., Moran M. How medicaid preventive services, medicaid health homes, and state innovation models are including community health workers center for health law and policy innovation Harvard Law School; May 30, 2015 http://www.chlpi.org/wp-content/uploads/2013/12/ACA-Opportunities-for-CHWsFINAL-8-12.pdf.
66. Garfield S.A., Malozowski S., Chin M.H., et al. Considerations for diabetes translational research in real-world settings. Diabetes Care 2003, 26(9):2670-2674. 10.2337/diacare.26.9.2670.
67. Dunkley A.J., Bodicoat D.H., Greaves C.J., et al. Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations a systematic review and meta-analysis. Diabetes Care 2014, 37(4):922-923. 10.2337/dc13-2195/-/DC1.
68. Centers for Disease Control Prevention Awareness of prediabetes-United States, 2005-2010. MMWR 2013, 62(11):209.
69. Center for Disease Control and Prevention Registry of Recognized Programs (Accessed October 19, 2015). https://nccd.cdc.gov/DDT_DPRP/State.aspx?STATE=ALL.
70. Yang K., Lee Y.S., Chasens E.R. Outcomes of health care providers' recommendations for healthy lifestyle among U.S. adults with prediabetes. Metab. Syndr. Relat. Disord. 2011, 9(3):231-237. 10.1089/met.2010.0112.
71. Moin T., Li J., Duru O.K., et al. Metformin prescription for insured adults with prediabetes from 2010 to 2012: a retrospective cohort study. Ann. Intern. Med. 2015, 162(8):542-548. 10.7326/M14-1773.
72. Schmittdiel J.A., Adams S.R., Segal J., et al. Novel use and utility of integrated electronic health records to assess rates of prediabetes recognition and treatment: brief report from an integrated electronic health records pilot study. Diabetes Care 2014, 37(2):565-568. 10.2337/dc13-1223.